|
C12ORF29 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.021700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.193610E-02 |
| Normal-vs-Stage2 |
8.272800E-01 |
| Normal-vs-Stage3 |
1.473560E-02 |
| Normal-vs-Stage4 |
9.436800E-04 |
| Stage1-vs-Stage2 |
3.362400E-01 |
| Stage1-vs-Stage3 |
5.302200E-01 |
| Stage1-vs-Stage4 |
2.019600E-01 |
| Stage2-vs-Stage3 |
2.234600E-01 |
| Stage2-vs-Stage4 |
1.345760E-01 |
| Stage3-vs-Stage4 |
7.207200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.588400E-02 |
| Normal-vs-AfricanAmerican |
1.5608000003553E-07 |
| Normal-vs-Asian |
1.037390E-01 |
| Caucasian-vs-AfricanAmerican |
7.57399999999908E-05 |
| Caucasian-vs-Asian |
6.525000E-01 |
| AfricanAmerican-vs-Asian |
3.575000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.819200E-03 |
| Normal-vs-Female |
1.170310E-02 |
| Male-vs-Female |
9.145200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.123560E-03 |
| Normal-vs-Age(41-60Yrs) |
1.884210E-02 |
| Normal-vs-Age(61-80Yrs) |
1.216330E-02 |
| Normal-vs-Age(81-100Yrs) |
2.481600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.061160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.654050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.118840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.793800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.860800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.531600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.929600E-01 |
| Normal-vs-Grade 2 |
4.715400E-01 |
| Normal-vs-Grade 3 |
1.97968999999798E-05 |
| Normal-vs-Grade 4 |
2.80320000001222E-06 |
| Grade 1-vs-Grade 2 |
5.201600E-01 |
| Grade 1-vs-Grade 3 |
2.801800E-01 |
| Grade 1-vs-Grade 4 |
1.002380E-01 |
| Grade 2-vs-Grade 3 |
1.720510E-03 |
| Grade 2-vs-Grade 4 |
2.413500E-04 |
| Grade 3-vs-Grade 4 |
1.714970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.427800E-01 |
| Normal-vs-ccB subtype |
2.248300E-04 |
| ccA subtype-vs-ccB subtype |
2.417700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.663800E-02 |
| Normal-vs-N1 |
1.301990E-02 |
| N0-vs-N1 |
1.811990E-01 |
|
|
